Retina Group of New England — Waterford, Connecticut

Retina Group of New England is a clinical research site located in Waterford, Connecticut, United States 06385.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Retina Group of New England has participated in 23 clinical trials with 8 currently active.

Therapeutic areas: Geographic Atrophy, Diabetic Macular Edema, Neovascular Age-related Macular Degeneration.

Sponsors: Hoffmann-La Roche, Ocular Therapeutix, Inc., Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Retina Group of New England?

Retina Group of New England has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Retina Group of New England conducted?

Retina Group of New England has 23 clinical trials on record, with 8 currently active. Their work covers Geographic Atrophy, Diabetic Macular Edema, Neovascular Age-related Macular Degeneration.

Is Retina Group of New England accredited by Crixeo Health?

Retina Group of New England has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Retina Group of New England?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.